United States · FDA National Drug Code directory
GUAIFENESIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-840_44f3065d-0001-622b-e063-6394a90a2775
- Product NDC
- 62207-840
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- GUAIFENESIN
- Labeler
- Granules India Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201218
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 1200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 BLISTER PACK in 1 CARTON (62207-840-71) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 62207-840-71
- 10000 TABLET, EXTENDED RELEASE in 1 BOX (62207-840-93) · 62207-840-93
- 4200 TABLET, EXTENDED RELEASE in 1 BAG (62207-840-99) · 62207-840-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →